Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) Apr. 6, 2025
Advanced Search
Volume 51 Issue 3
May  2020
Turn off MathJax
Article Contents
Abstract
References
Related Articles
WEI Rong-rong, WANG Cheng-cheng, LI Da-jiang, et al. Diagnostic Value of Abnormal Prothrombin in HBV-related AFP-negative Hepatocellular Carcinoma[J]. Journal of Sichuan University (Medical Sciences), 2020, 51(3): 411-415. DOI: 10.12182/20200560208
Citation: WEI Rong-rong, WANG Cheng-cheng, LI Da-jiang, et al. Diagnostic Value of Abnormal Prothrombin in HBV-related AFP-negative Hepatocellular Carcinoma[J]. Journal of Sichuan University (Medical Sciences), 2020, 51(3): 411-415. DOI: 10.12182/20200560208
shu

Diagnostic Value of Abnormal Prothrombin in HBV-related AFP-negative Hepatocellular Carcinoma

  • 1.

    Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, China

  • 2.

    Innovation Center of Nursing Research, West China School of Medicine and West China Hospital, Sichuan University, Chengdu 610041, China

More Information
  • Corresponding author:

    LIU Kai, E-mail: liubusiness@163.com

  • Received Date: June 16, 2019
  • Revised Date: November 08, 2019
  • Available Online: May 24, 2020
  • Published Date: May 19, 2020
    Abstract
  •   Objective  To evaluate the diagnostic value of abnormal prothrombin (DCP) in Alpha-fetoproteins (AFP)-negative (AFP≤20 ng/mL) hepatocellular carcinoma and the relationship between DCP level and Child-Pugh grade, tumor size, TNM stage as well as differentiation.
      Methods  The inpatients diagnosed with hepatitis B-related liver disease were collected from June 2016 to December 2017, The diagnostic efficacy of DCP for AFP-negative HCC was analyzed by ROC. Area under the curve (AUC), the best cut point, sensitivity, specificity, positive predictive value and negative predictive value were calculated. The relationship between DCP levels and the clinical characteristic of HCC was analyzed.
      Results  A total of 459 hepatitis B markers positive patients were included, including 136 cases of hepatocellular carcinoma, 173 cases of hepatitis B cirrhosis and 150 cases of chronic hepatitis B. DCP in AFP-negative hepatocellular carcinoma group was significantly higher than that in non-HCC group (CHB and LC) (P<0.05). The AUC of DCP was 0.858, P<0.05. The optimal cut-off point for the diagnosis of hepatocellular carcinoma was 61 mAU/mL. The corresponding sensitivity, specificity, positive predictive value and negative predictive value were 72.8%, 88.2%, 61.1% and 89.7%, respectively. In different size of hepatocellular carcinoma, DCP level of those with diameter>3 cm was significantly higher than those with diameter≤3 cm (P<0.05). In different TNM stages, DCP level in stage Ⅱ and Ⅲ was significantly higher than that in stage Ⅰ (P<0.05). There was no significant difference of DCP level among different Child-Pugh grades and differentiation (P>0.05).
      Conclusion  DCP has diagnostic value for AFP-negative hepatocellular carcinoma, its level may reflects the degree of tumor progression.
    • FullText(HTML)
    • References (21)
  • [1]
    ZHONG J H, KE Y, WANG Y Y, et al. Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension. Gut,2015,64(3): 520–521. DOI: 10.1136/gutjnl-2014-308139
    [2]
    KHALILI K, MENEZES R, KIM T K, et al. The effectiveness of ultrasound surveillance for hepatocellular carcinoma in a Canadian centre and determinants of its success. Can J Gastroenterol Hepatol,2015,29(5): 267–273. DOI: 10.1155/2015/563893
    [3]
    WILSON S R, LYSHCHIK A, PISCAGLIA F, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY),2018,43(1): 127–142. DOI: 10.1007/s00261-017-1250-0
    [4]
    TENFLO J, SUTTIE J W. Vitamin K-dependent formation of gamma-carboxyglutamic acid. Annu Rev Biochem,1977,46(1): 157–172. DOI: 10.1146/annurev.bi.46.070177.001105
    [5]
    SEO S I, KIM H S, KIM W J, et al. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol,2015,21(13): 3928–3935. DOI: 10.3748/wjg.v21.i13.3928
    [6]
    Clinical practice guidelines for hepatocellular carcinoma differ between Japan, United States, and Europe. Liver Cancer, 2015, 4(2): 85-95. doi: 10.1159/000367730.
    [7]
    LIU Z, JIANG Y, YUAN H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol,2019,70(4): 674–683. DOI: 10.1016/j.jhep.2018.12.001
    [8]
    中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 临床肝胆病杂志,2019,35(12): 2648–2669.
    [9]
    中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 中国实用外科杂志,2020,40(2): 121–138.
    [10]
    SHE S, XIANG Y, YANG M, et al. C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. Int J Oncol,2015,47(2): 543–554. DOI: 10.3892/ijo.2015.3042
    [11]
    SENGUPTA S, PARIKH N D. Biomarker development for hepatocellular carcinoma early detection: current and future perspectives. Hepat Oncol,2017,4(4): 111–122. DOI: 10.2217/hep-2017-0019
    [12]
    SONG P P, XIA J F, INAGAKI Y, et al. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol,2016,22(1): 262–274. DOI: 10.3748/wjg.v22.i1.262
    [13]
    CHEN H, ZHANG Y, LI S, et al. Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Manag Res,2018,10: 1947–1958. DOI: 10.2147/CMAR.S167036
    [14]
    CHEN J, WU G, LI Y. Evaluation of serum des-gamma-carboxy prothrombin for the diagnosis of hepatitis B virus-related hepatocellular carcinoma: a meta-analysis. Dis Markers,2018,2018: 8906023[2019-05-13]. https://doi.org/10.1155/2018/8906023.
    [15]
    JI J, WANG H, LI Y, et al. Diagnostic evaluation of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatitis B virus-related hepatocellular carcinoma in China: a large-scale, multicentre study. PLoS One,2016,11(4): e0153227[2019-05-13]. https://doi.org/10.1371/journal.pone.0153227.
    [16]
    LEE S, RHIM H, KIM Y S, et al. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Liver Int,2016,36(4): 580–587. DOI: 10.1111/liv.12991
    [17]
    LI Y, CHEN J. Serum des-gamma-carboxy prothrombin for diagnosis of adult primary cancer in liver. J Coll Physicians Surg Pak,2019,29(10): 972–976. DOI: 10.29271/jcpsp.2019.10.972
    [18]
    LI G J, CHEN Q Y, HARRISON T J, et al. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T.{1762}, A.{1764}), a prospective study. Cancer Biomark,2017,18(3): 241–248. DOI: 10.3233/CBM-160131
    [19]
    PARK S J, JANG J Y, JEONG S W, et al. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma. Medicine (Baltimore),2017,96(11): e5811[2019-05-13]. https://doi.org/10.1097/MD.0000000000005811.
    [20]
    XING H, ZHENG Y J, HAN J, et al. Protein induced by vitamin K absence or antagonist-Ⅱ versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: a systematic review with meta-analysis. Hepatobiliary Pancreat Dis Int,2018,17(6): 487–495. DOI: 10.1016/j.hbpd.2018.09.009
    [21]
    BEST J, BECHMANN L P, SOWA J P, et al. GALAD Score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol,2020,18(3): 728–735. DOI: 10.1016/j.cgh.2019.11.012
    • Relative Articles

  • Related Articles

    [1]CHEN Weiguang, HE Chunyu, WEN Bin, SUN Haitao, YANG Xuemei, CHEN Weicong, LIU Yang, ZHONG Binglian, HE Songqi. Biejiajian Pill Regulates Ferroptosis in Hepatocellular Carcinoma Cells via p62/Keap1/NRF2 Signaling Pathway: A Mechanism Study[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2025, 56(1): 51-58. DOI: 10.12182/20250160502
    [2]XU Rushuang, YANG Lingxiao, SONG Guanbin. Plectin Promotes the Migration of Hepatocellular Carcinoma Cells Through Inducing F-actin Polymerization[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2024, 55(1): 60-67. DOI: 10.12182/20240160106
    [3]FENG Tang, YANG Xinrui, WANG Qiwei, LIU Xiaoheng. Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2024, 55(1): 6-12. DOI: 10.12182/20240160203
    [4]RAO Jing-jing, ZENG Feng, JI Man-shan, XU Xiang, YU Chun-fang, YANG Jing, LIU Long, LIU Zhi-xin. PreS1 Antigen of HBV Down-Regulates MHC-Ⅰ on the Surface of Hepatocytes and Promotes Hepatocarcinogenesis[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2022, 53(2): 285-290. DOI: 10.12182/20220360509
    [5]DAI Xue-mei, ZHANG Xi, ZHANG Xuan, ZHOU Jing, DUAN Xiao-xia, HUANG Jin-cheng, LIAO Yu-ting, YUAN Ping. Study on Behavioral Factors Affecting the Risk of New HBV Infection among Diabetic Patients[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2021, 52(5): 772-777. DOI: 10.12182/20210960301
    [6]CAO Dan, YU Le, WANG Li-chun.. Bioinformatics Analysis of Hepatocellular Carcinoma Related Gene and Construction of a Protein-Protein Interaction Network[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2018, 49(6): 899-903.
    [7]QIN Li, YANG Xiao-ling, LI Chuan, LUO Yan-li. Predictive Value of Platelet to Lymphocyte Ratio and Prognostic Nutritional Index on Prognosis of Hepatocellular Carcinoma after Liver Resection[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2018, 49(4): 645-648.
    [8]CHEN Li-yu, WANG Juan, WANG Wei-ya. et al. Correlation Between Serological Indices and Liver Histological Pathology in Patients with HBV Infection[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2015, 46(4): 641-644.
    [9]XU Da-heng, CHEN Lin, TANG Cheng-wei, WANG Chun-hui, MENG Wen-tong. Effect of Cyclooxygenase-2 Inhibitor on CD4+ CD25+ Regulatory T Cells in Mouse Hepatocellular Carcinoma[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2013, 44(4): 545-549.
    [10]MU Xia, CHEN Yao, WANG Sui-hai, LI Ming. The Effect of Nicotinamide N-methytransferase Overexpression on Biological Behaviors of SMMC7721 Hepatocellar Carcinoma Cell Line[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2013, 44(2): 193-195,217.
    • Supplements (0)

  • Cited by

    Periodical cited type(5)

    1. 李嘉舟，谢静，周学东. 基质细胞衍生因子1α通过Akt信号通路抑制软骨细胞凋亡并促进自噬. 四川大学学报(医学版). 2024(01): 53-59 .
    2. 蒋诗情，汪余嘉，雷永芳，陈子春. HIF-1介导血管内皮功能障碍的机制研究进展. 浙江医学. 2024(09): 992-997 .
    3. 刘成，杨红起，郝同玉. 骨关节炎中不同组织细胞相互作用的研究进展. 医药论坛杂志. 2023(08): 109-113 .
    4. 陈永洪，顾兴科. PI3K/Akt在膝骨关节炎中调控软骨细胞凋亡的作用机制. 医学信息. 2023(20): 184-188 .
    5. 李舒雅，陈京京，刘腾达，王淑红. 低氧诱导因子-1α在颌骨缺损重建修复中的应用及研究进展. 口腔颌面修复学杂志. 2022(06): 461-466 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views (3965) PDF downloads (109) Cited by(8)
    • Website Copyright © Editorial Office of Journal of Sichuan University (Medical Sciences).
    • 17, Section 3, Renmin Nanlu Road, Wuhou District, Chengdu 610041, People’s Republic of China
    • Tel：+86-028-85501320 +86-028-85500106       E-mail: scuxbyxb@scu.edu.cn

    Official website of Journal of Sichuan University (Medical Sciences)

    WeChat official account of Journal of Sichuan University (Medical Sciences)

    WeChat subscription account of Journal of Sichuan University (Medical Sciences)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return